As someone with a sound scientific background, immersed in the technical side of this work, I’ve seen firsthand how the field ...
Founded in 2018, Metagenomi is using a Nobel prize-winning approach developed by Jennifer Doudna and Emmanuelle Charpentier ...
Generic versions of biologic drugs could hit the market without human trials and allow the market forces to bring down costs, ...
Dr. Pete, chief scientist at Dirty Labs, explained how his company managed to create effective, sustainable cleaning products ...
In a world first, a bespoke gene-editing therapy benefited one child. Now researchers plan to launch a clinical trial of the approach ...
In a world first, a bespoke gene-editing therapy benefitted one child. Now reseachers plan to launch a clinical trial of the ...
Recognized in the Biotechnology category of the 2025 Top Innovations contest, small Cas12l nucleases are versatile, ...
Lozano is a rare disease mom, neuroscience Ph.D. candidate at UC Davis, and board member for the PURA Syndrome Foundation. In May, a historic moment in science and medicine was captured in a single ...
Please provide your email address to receive an email when new articles are posted on . A CRISPR-Cas9-based therapy reduced transthyretin levels in patients with hereditary amyloidosis and ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min A small S.F. biotech with ties ...